Science Explorer Back to mapMap
Discussion
Institution · German Center for Infection Research

Most cited papers from German Center for Infection Research

German Center for Infection Research

What are the most cited papers from German Center for Infection Research?

The most cited paper from German Center for Infection Research is "SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor" (Markus Hoffmann, Hannah Kleine‐Weber, Simon Schroeder et al., 2020), with 21,493 citations. Next come "Natural products in drug discovery: advances and opportunities" (5,395) and "The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China" (4,033).

Showing 50 of 59 papers. Every paper with more than 820 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Markus Hoffmann, Hannah Kleine‐Weber, Simon Schroeder et al. · Cell Open access 8 Mar 2020 21,493
2 Natural products in drug discovery: advances and opportunities Atanas G. Atanasov et al. · Nature Reviews Drug Discovery ReviewOpen access 28 Jan 2021 5,395
3 The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China David S.C. Hui, Esam I. Azhar, Tariq A. Madani et al. · International Journal of Infectious Diseases Open access 14 Jan 2020 4,033
4 The repertoire of mutational signatures in human cancer Ludmil B. Alexandrov et al. · Nature Open access1,384 authors 5 Feb 2020 3,854
5 Host microbiota constantly control maturation and function of microglia in the CNS Daniel Erny, Anna Lena Hrabě de Angelis, Diego Adhemar Jaitin et al. · Nature Neuroscience Open access Jun 2015 3,611
6 ResFinder 4.0 for predictions of phenotypes from genotypes Valeria Bortolaia et al. · Journal of Antimicrobial Chemotherapy Open access 16 Jul 2020 3,475
7 Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors Linlin Zhang, Daizong Lin, Xinyuanyuan Sun et al. · Science Open access 20 Mar 2020 3,465
8 Pan-cancer analysis of whole genomes Lauri A. Aaltonen et al. · Nature Open access1,324 authors 5 Feb 2020 3,360
9 antiSMASH 5.0: updates to the secondary metabolite genome mining pipeline Kai Blin, Simon J. Shaw, Kat Steinke et al. · Nucleic Acids Research Open access 17 Apr 2019 3,159
10 A new antibiotic kills pathogens without detectable resistance Losee Lucy Ling et al. · Nature Open access 5 Jan 2015 2,471
11 Spread of Artemisinin Resistance in Plasmodium falciparum Malaria Elizabeth A. Ashley et al. · New England Journal of Medicine Open access 30 Jul 2014 2,295
12 antiSMASH 3.0—a comprehensive resource for the genome mining of biosynthetic gene clusters Tilmann Weber, Kai Blin, Srikanth Duddela et al. · Nucleic Acids Research Open access 6 May 2015 1,937
13 Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium Oliver A. Cornely et al. · The Lancet Infectious Diseases Open access 4 Nov 2019 1,841
14 Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients Nisreen M.A. Okba, Marcel A. Müller, Wentao Li et al. · Emerging infectious diseases Open access 8 Apr 2020 1,676
15 Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment Jonas Schulte-Schrepping et al. · Cell Open access140 authors 5 Aug 2020 1,642
16 Methicillin-resistant Staphylococcus aureus Andie S. Lee, Hermı́nia de Lencastre, Javier Garau et al. · Nature Reviews Disease Primers ReviewOpen access 30 May 2018 1,598
17 Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline Andrew J. Ullmann et al. · Clinical Microbiology and Infection Open access 18 Mar 2018 1,576
18 Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report Peter Malfertheiner, Françis Mégraud, Theodore Rokkas et al. · Gut Open access 8 Aug 2022 1,507
19 Functional overlap of the Arabidopsis leaf and root microbiota Yang Bai, Daniel B. Müller, Girish Srinivas et al. · Nature 30 Nov 2015 1,442
20 The interplay between microbial communities and soil properties Laurent Philippot, Claire Chenu, Andreas A. Kappler et al. · Nature Reviews Microbiology Review 20 Oct 2023 1,409
21 Neuropathology of patients with COVID-19 in Germany: a post-mortem case series Jakob Matschke et al. · The Lancet Neurology Open access 5 Oct 2020 1,372
22 EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research Jan Van Deun et al. · Nature Methods 28 Feb 2017 1,345
23 Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease Stephan Johannes Ott, M Musfeldt, D F Wenderoth et al. · Gut Open access 13 Apr 2004 1,339
24 NASH limits anti-tumour surveillance in immunotherapy-treated HCC Dominik Reinhard Pfister et al. · Nature Open access110 authors 24 Mar 2021 1,304
25 Structures and distributions of SARS-CoV-2 spike proteins on intact virions Zunlong Ke, Joaquı́n Otón, Kun Qu et al. · Nature Open access 17 Aug 2020 1,296
26 Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions Alessia Savoldi, Elena Carrara, David Yates Graham et al. · Gastroenterology ReviewOpen access 7 Jul 2018 1,288
27 The Human Phenotype Ontology in 2021 Sebastian Köhler et al. · Nucleic Acids Research Open access 16 Nov 2020 1,280
28 Towards the sustainable discovery and development of new antibiotics Marcus Miethke et al. · Nature Reviews Chemistry ReviewOpen access 19 Aug 2021 1,192
29 Helicobacter pylori infection Peter Malfertheiner, Maria Constanza Camargo, Emad M. El-Omar et al. · Nature Reviews Disease Primers ReviewOpen access 20 Apr 2023 1,186
30 The evolutionary history of 2,658 cancers Moritz Gerstung et al. · Nature Open access1,441 authors 5 Feb 2020 1,149
31 Mapping the human genetic architecture of COVID-19 COVID-19 Host Genetics Initiative et al. · Nature Open access3,896 authors 8 Jul 2021 1,130
32 Proteomics of SARS-CoV-2-infected host cells reveals therapy targets Denisa Bojková, Kevin Klann, Benjamin Koch et al. · Nature Open access 14 May 2020 1,117
33 Changes to taxonomy and the International Code of Virus Classification and Nomenclature ratified by the International Committee on Taxonomy of Viruses (2018) Andrew M. Q. King et al. · Archives of Virology Open access 12 May 2018 1,105
34 mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant Wilfredo Francisco Garcia-Beltran, Kerri St. Denis, Angelique Hoelzemer et al. · Cell Open access 6 Jan 2022 1,100
35 The immunology of hepatocellular carcinoma Marc Ringelhan, Dominik Reinhard Pfister, Tracy O’Connor et al. · Nature Immunology 26 Jan 2018 1,099
36 Using the miraEST Assembler for Reliable and Automated mRNA Transcript Assembly and SNP Detection in Sequenced ESTs Bastien Chevreux, Thomas Pfisterer, Bernd Drescher et al. · Genome Research Open access 12 May 2004 1,092
37 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine) Mical Paul et al. · Clinical Microbiology and Infection Open access 16 Dec 2021 1,075
38 Hosts and Sources of Endemic Human Coronaviruses Victor M. Corman, Doreen Muth, Daniela Niemeyer et al. · Advances in virus research Book chapterOpen access 2018 1,059
39 Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management David W. Denning, J. Cadranel, Catherine Beigelman‐Aubry et al. · European Respiratory Journal 23 Dec 2015 1,049
40 Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) Andrea Cossarizza et al. · European Journal of Immunology Open access436 authors Oct 2019 1,014
41 Macrophage defense mechanisms against intracellular bacteria Günter Weiß, Ulrich Emil Schaible · Immunological Reviews ReviewOpen access 20 Feb 2015 1,014
42 Patterns of somatic structural variation in human cancer genomes Yilong Li et al. · Nature Open access1,411 authors 5 Feb 2020 1,005
43 Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 Christopher J L Murray et al. · The Lancet Open access366 authors 21 Jul 2014 998
44 A cellular census of human lungs identifies novel cell states in health and in asthma Felipe A. Vieira Braga et al. · Nature Medicine Open access 17 Jun 2019 991
45 Critical Assessment of Metagenome Interpretation—a benchmark of metagenomics software Alexander Sczyrba et al. · Nature Methods Open access 2 Oct 2017 983
46 Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance Philipp A. Koehler et al. · The Lancet Infectious Diseases Open access 16 Dec 2020 977
47 Human commensals producing a novel antibiotic impair pathogen colonization Alexander Zipperer, Martin C. Konnerth, Claudia Laux et al. · Nature 26 Jul 2016 969
48 The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic Markus Hoffmann, Nadine Krüger, Sebastian R. Schulz et al. · Cell Open access 24 Dec 2021 959
49 Outbreak of human monkeypox in Nigeria in 2017–18: a clinical and epidemiological report Adesola F. Yinka-Ogunleye et al. · The Lancet Infectious Diseases Open access 5 Jul 2019 959
50 Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline Charles L. Daley et al. · European Respiratory Journal Open access Jul 2020 939

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.